Premium
Targeting constitutively active STAT3 in chronic lymphocytic leukemia: A clinical trial of the STAT3 inhibitor pyrimethamine with pharmacodynamic analyses
Author(s) -
Brown Jennifer R.,
Walker Sarah R.,
Heppler Lisa N.,
Tyekucheva Svitlana,
Nelson Erik A.,
Klitgaard Josephine,
Nicolais Maria,
Kroll Yasmin,
Xiang Michael,
Yeh Jennifer E.,
Chaudhury Mousumi,
Giaccone Zachary T.,
Fernandes Stacey M.,
Jacobsen Eric D.,
Fisher David C.,
Freedman Arnold S.,
Davids Matthew S.,
Supko Jeffrey G.,
Wu Catherine,
Frank David A.
Publication year - 2021
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.26084
Subject(s) - pharmacodynamics , stat3 , pharmacology , medicine , chronic lymphocytic leukemia , clinical trial , cancer research , leukemia , oncology , immunology , biology , pharmacokinetics , signal transduction , biochemistry